Herbert Smith Freehills’ Priyanka Madan reports on a case involving a Merck SPC which was keenly anticipated by both ...

Sanofi has shared a deeper dive into its 469 million euro ($491 million) bowel disease bet, publishing phase 2 data that ...

Vivek Ramaswamy, endorsed by Donald Trump and Elon Musk, enters the Ohio gubernatorial race. Ramaswamy promises voters tax ...

The partners will test Summit’s ivonescimab alongside Pfizer’s antibody-drug conjugates in hopes of finding “potentially ...

A team has used a process known as DNA origami to make electrochemical sensors that can quickly detect and measure biomarkers.

The rising global cancer incidence is a key factor driving the CD47 inhibitors market, as the demand for novel therapies grows. Recent clinical trial ...

While main results from a platform study of four experimental drugs for amyotrophic lateral sclerosis are negative, it shows ...

Detailed results presented at a medical congress help reinforce analyst expectations the drug, called duvakitug, will be competitive with other Crohn’s, colitis medicines in testing.

ASCO’s updated guidelines for advanced ovarian cancer emphasize health equity and provide new recommendations for HIPEC while ...

KEYTRUDA monotherapy is the recommended first-line treatment for recurrent or metastatic HNSCC with high PD-L1 expression, ...

Cosette Pharmaceuticals, based in Bridgewater, N.J., with a pharmaceutical production plant in Lincolnton, N.C., will acquire ...

Institutional Class shares of Columbia Dividend Income Fund returned -1.34% for Q4 2024. Click here to read the full ...